| http://www.w3.org/ns/prov#value | - NMDA antagonists such as ketamine produce psychosis and cognitive impairment in human users (Krystal et al. 1994; Lahti et al. 2001; Malhotra et al. 1996; Newcomer et al. 1999), exacerbate psychotic symptoms (Lahti et al. 1995; Lahti et al. 2001; Malhotra et al. 1997) and recreate schizophrenia-like changes in the laboratory (Behrens et al. 2007; Ehrlichman et al. 2008; Lazarewicz et al. 2010; Mog
|
